title: Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab.
authors.forename: Martin
authors.initials: M
authors.lastname: Wermke
authors.forename: Malte
authors.initials: M
authors.lastname: von Bonin
authors.forename: Siegmund
authors.initials: S
authors.lastname: Gehrisch
authors.forename: Gabriele
authors.initials: G
authors.lastname: Siegert
authors.forename: Gerhard
authors.initials: G
authors.lastname: Ehninger
authors.forename: Uwe
authors.initials: U
authors.lastname: Platzbecker
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; D005169:Factor VIII